DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Roth Capital Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces $12 Price Target

Roth Capital analyst Zegbeh Jallah initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and a $12 price target.

Benzinga · 03/13/2020 09:27

Roth Capital analyst Zegbeh Jallah initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and a $12 price target.